Literature DB >> 8822880

Improved purification methods for calf-derived Cryptosporidium parvum oocysts using discontinuous sucrose and cesium chloride gradients.

M J Arrowood1, K Donaldson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8822880     DOI： 10.1111/j.1550-7408.1996.tb05015.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN： 1066-5234            Impact factor:   3.346


× No keyword cloud information.
  49 in total

Review 1.  In vitro cultivation of cryptosporidium species.

Authors:  Michael J Arrowood
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

2.  Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis.

Authors:  Alvaro Benitez; Jeffrey W Priest; Humphrey N Ehigiator; Nina McNair; Jan R Mead
Journal:  Vaccine       Date:  2011-10-01       Impact factor: 3.641

3.  Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.

Authors:  Suresh Kumar Gorla; Nina N McNair; Guangyi Yang; Song Gao; Ming Hu; Venkatakrishna R Jala; Bodduluri Haribabu; Boris Striepen; Gregory D Cuny; Jan R Mead; Lizbeth Hedstrom
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

4.  Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of Cryptosporidium Infection.

Authors:  Frederick S Buckner; Ranae M Ranade; J Robert Gillespie; Sayaka Shibata; Matthew A Hulverson; Zhongsheng Zhang; Wenlin Huang; Ryan Choi; Christophe L M J Verlinde; Wim G J Hol; Atsuko Ochida; Yuichiro Akao; Robert K M Choy; Wesley C Van Voorhis; Sam L M Arnold; Rajiv S Jumani; Christopher D Huston; Erkang Fan
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

5.  Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.

Authors:  Deborah A Schaefer; Dana P Betzer; Kylie D Smith; Zachary G Millman; Hannah C Michalski; Sarah E Menchaca; Jennifer A Zambriski; Kayode K Ojo; Matthew A Hulverson; Samuel L M Arnold; Kasey L Rivas; Rama S R Vidadala; Wenlin Huang; Lynn K Barrett; Dustin J Maly; Erkang Fan; Wesley C Van Voorhis; Michael W Riggs
Journal:  J Infect Dis       Date:  2016-10-17       Impact factor: 5.226

6.  Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice.

Authors:  Michael Imboden; Michael W Riggs; Deborah A Schaefer; E Jane Homan; Robert D Bremel
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

7.  Immunomagnetic separation of Cryptosporidium parvum from source water samples of various turbidities.

Authors:  Z Bukhari; R M McCuin; C R Fricker; J L Clancy
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

8.  Effects of seeding procedures and water quality on recovery of Cryptosporidium oocysts from stream water by using U.S. Environmental Protection Agency Method 1623.

Authors:  Donna S Francy; Otto D Simmons; Michael W Ware; Emma J Granger; Mark D Sobsey; Frank W Schaefer
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

9.  Inactivation of Cryptosporidium parvum oocysts in fresh apple cider by UV irradiation.

Authors:  D E Hanes; R W Worobo; P A Orlandi; D H Burr; M D Miliotis; M G Robl; J W Bier; M J Arrowood; J J Churey; G J Jackson
Journal:  Appl Environ Microbiol       Date:  2002-08       Impact factor: 4.792

10.  Comparison of in vitro cell culture and a mouse assay for measuring infectivity of Cryptosporidium parvum.

Authors:  Paul A Rochelle; Marilyn M Marshall; Jan R Mead; Anne M Johnson; Dick G Korich; Jeffrey S Rosen; Ricardo De Leon
Journal:  Appl Environ Microbiol       Date:  2002-08       Impact factor: 4.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.